These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2278038)
1. Studies in patients with bleeding disorders show that platelet-vessel interaction is important for thromboxane formation in bleeding time wounds. Gerrard JM; Singhroy S; Duta E; Nosek-Cenkowska B; Israels SJ; Israels ED Thromb Res; 1990 Oct; 60(1):79-85. PubMed ID: 2278038 [TBL] [Abstract][Full Text] [Related]
2. Changes of plasma 6-keto-PGF1 alpha and thromboxane B2 levels and platelet aggregation after tourniquet ischemia on the upper limb in normal subjects and patients with ischemic heart disease. Chen LS; Ito T; Ogawa K; Satake T Jpn Circ J; 1982 Jul; 46(7):651-6. PubMed ID: 6896534 [TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension. Chen LS; Ito T; Ogawa K; Shikano M; Satake T Jpn Heart J; 1984 Nov; 25(6):1001-9. PubMed ID: 6549401 [TBL] [Abstract][Full Text] [Related]
4. Prostacyclin and thromboxane in diabetes. Ylikorkala O; Kaila J; Viinikka L Br Med J (Clin Res Ed); 1981 Oct; 283(6300):1148-50. PubMed ID: 6794795 [TBL] [Abstract][Full Text] [Related]
5. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2. Ylikorkala O; Mäkilä UM; Viinikka L Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904 [TBL] [Abstract][Full Text] [Related]
6. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin. Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545 [TBL] [Abstract][Full Text] [Related]
7. Prostacyclin and thromboxane in diabetic children. Kaar ML; Kaapa P; Viinikka L; Ylikorkala O Prostaglandins Leukot Med; 1983 Jul; 11(3):339-44. PubMed ID: 6351104 [TBL] [Abstract][Full Text] [Related]
8. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions. Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369 [TBL] [Abstract][Full Text] [Related]
9. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [TBL] [Abstract][Full Text] [Related]
10. Studies of thromboxane B2, platelet factor 4, and fibrinopeptide A in bleeding-time blood of patients deficient in von Willebrand factor, platelet glycoproteins Ib and IIb-IIIa, and storage granules. Weiss HJ; Lages B Blood; 1993 Jul; 82(2):481-90. PubMed ID: 8329704 [TBL] [Abstract][Full Text] [Related]
11. Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion. Kangasaho M; Hillbom M; Kaste M; Wuorela H; Vapaatalo H Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():223-8. PubMed ID: 6303086 [No Abstract] [Full Text] [Related]
12. A role for prostacyclin in bruising symptomatology. Gerrard JM; Duta E; Nosek-Cenkowska B; Singhroy S; Cheang M; Kobrinsky NL Pediatrics; 1992 Jul; 90(1 Pt 1):33-6. PubMed ID: 1614775 [TBL] [Abstract][Full Text] [Related]
13. Measurements of 6-keto-prostaglandin F1 alpha and thromboxane B2 in bleeding time blood: relation to bleeding and vascular disorders? Gerrard JM Can J Physiol Pharmacol; 1989 Aug; 67(8):922-8. PubMed ID: 2688855 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin. Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252 [TBL] [Abstract][Full Text] [Related]
15. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Nowak J; Murray JJ; Oates JA; FitzGerald GA Circulation; 1987 Jul; 76(1):6-14. PubMed ID: 3297389 [TBL] [Abstract][Full Text] [Related]
16. [Effects of ligustrazine on plasma platelet aggregation rate, thromboxane B2, 6-keto-prostaglandin F1 alpha and von Willebrand's factor in patients with acute onset of cor pulmonale]. Wang S; Xin K; Ma D Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Oct; 19(10):602-4. PubMed ID: 11783174 [TBL] [Abstract][Full Text] [Related]
17. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. Kyrle PA; Eichler HG; Jäger U; Lechner K Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295 [TBL] [Abstract][Full Text] [Related]
19. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin. Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766 [TBL] [Abstract][Full Text] [Related]